Investors

Investors

Investors

Featured

Novartis Quarterly Financial Results

Novartis delivered sales growth across all divisions (cc) as growth drivers, including Cosentyx and Entresto, more than ...
Read More

Share Price

CHF as of Jun 23, 17:31 CEST
USD as of Jun 23, 16:02 EDT
View stock performance

Media Release / Jun 23
NEJM publishes full analysis of Rydapt® (midostaurin) Phase III RATIFY trial in newly diagnosed FLT3-mutated acute myeloid leukemia (AML)

Read More

Media Release / Jun 23
Novartis Kisqali® (ribociclib) receives positive CHMP opinion as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor

Read More

In this section

Event Calendar
Find out about upcoming Novartis Investor Relations events.
Company Overview
Learn about Novartis leaders, corporate governance, our clinical pipeline and more.
Share Data & Analysis
Access information on Novartis share performance and dividend payouts.
Financial Data
Review and download annual and quarterly reports, SEC filings and product sales information.
Shareholder Information
Find information for shareholders and answers to frequently asked questions.
Investor Contact
For questions about Investor Relations or the share registry, please contact our team.

Quick Links

News
Novartis Annual Report 2016
Shareholder Information
Annual General Meeting
Investors
Novartis Fact Sheet
Shareholder Information
For Japanese Investors
Corporate Responsibility

We apply our expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of our business strategy.

Read More